4D Molecular Therapeutics Inc (FDMT)
ETFs that hold 4D Molecular Therapeutics Inc (FDMT)
4D Molecular Therapeutics Inc is held by 6 ETFs tracked in our database. The largest position is held by XBI (0.15%), a sector fund. The remaining funds hold it at 0.04% or less. The largest holders are mostly sector and broad-market funds.
ETFs holding 4D Molecular Therapeutics Inc (FDMT) in our database, ranked by portfolio weight.
Symbol | Name | Weight |
|---|---|---|
| XBI | SPDR S&P Biotech ETF | 0.15% |
| IBB | iShares Biotechnology ETF | 0.04% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | <0.01% |
| VTI | Vanguard Total Stock Market ETF | <0.01% |
| SCHB | Schwab US Broad Market ETF | <0.01% |
Which ETFs hold 4D Molecular Therapeutics Inc (FDMT)?
The ETFs with the largest positions in 4D Molecular Therapeutics Inc (FDMT) are: SPDR S&P Biotech ETF (XBI, 0.15%); iShares Biotechnology ETF (IBB, 0.04%); iShares Russell 2000 Value ETF (IWN, 0.03%); iShares Core S&P Total U.S. Stock Market ETF (ITOT, <0.01%); Vanguard Total Stock Market ETF (VTI, <0.01%). The full list, ranked by weight, is in the table.
How many ETFs hold 4D Molecular Therapeutics Inc (FDMT)?
4D Molecular Therapeutics Inc (FDMT) is held by 6 ETFs tracked in our database. The largest position is in XBI, where it makes up 0.15% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. XBI holds 4D Molecular Therapeutics Inc (FDMT) at 0.15%, and the simple average weight across the 6 funds is 0.04%.